LGND (Ligand Pharma) Yalpi marja

Ligand Pharma (LGND) korporativ emblemasi va logotipi

Ligand Pharmaceuticals (LGND) daromadlari litsenziyalash royalti to'lovlariga va hamkorlarining klinik muvaffaqiyatlariga bog'liq. Valo daromadlarining o'zgarishi xarajatlar chegirilgandan keyingi foyda dinamikasini aks ettiradi, bunda 81.60 ko'rsatkichi ushbu darajani belgilaydi. Captisol ekotizimi barqaror pul oqimini kafolatlaydi, ishlab chiqarish zanjirlarining yo'qligi esa holdingning logistika xarajatlarini butunlay yo'qqa chiqaradi.

LGND - Ligand Pharmaceuticals Incorporated Yalpi marja 04.07.2022 - 20.11.2026 oraligʻida

Ligand Pharma (LGND) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- bozor narxi va tahlilchilarning maqsadli narxlari:
Fundamental baholash:Ligand (LGND)
Ligand Pharmaceuticals Incorporated tomonidan chiqariladigan mahsulotlar

Yalpi marja bevosita ishlab chiqarish xarajatlaridan keyin qolgan daromad qismini o'lchaydi hamda operatsion samaradorlik va biznesning narx belgilash imkoniyatlarining asosiy ko'rsatkichi bo'lib xizmat qiladi. Captisol platformasini royalti orqali monetizatsiya qiluvchi Ligand Pharmaceuticals (LGND) uchun yalpi marjadagi har qanday og'ish yuqori marjali litsenziyalash to'lovlari oqimlarining barqarorligidan dalolat beradi, bu esa investorlarga ushbu xavfsiz modelning tashqi zarbalarga nisbatan chidamliligini baholash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda marjasi Haleon PLC (HLN)|Yalpi foyda bo'yicha rentabellik KVUE|Yalpi foyda marjasi Verona Pharma Inc. VRNA|Yalpi marja MENS|Yalpi marja amneal.com (AMRX)|Yalpi marja PRGO (perrigo.com)|Alvotech SA (ALVO) - Yalpi foyda marjasi|Liquidia Inc. - Yalpi marja|Sotuvning yalpi marjinal rentabelligi Galapagos Corp (GLPG)|ANI Pharmaceuticals (ANIP) - Yalpi rentabellik|Sotuvning yalpi rentabelligi MNKD|Yalpi rentabellik Amphastar Pharmaceuticals, Inc.|Pacira Pharmaceuticals (PCRX) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja SPRY|TBPH - Yalpi foyda marjasi|Aquestive Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi marja scpharmaceuticals.com SCPH|Tectonic - Yalpi marja|TNXP - Yalpi marja|SXTC: Yalpi marja|Eupraxia Pharma - Yalpi foyda normasi|BHST (bioharvest.com) - Yalpi marja|Sotuvning yalpi rentabelligi EXOZ (invizyne.com)|Yalpi marja ORMP|Yalpi foyda bo'yicha sotuv rentabelligi Entera Bio|Yalpi marja HYFT (MindWalk Holdings, Inc.)|ABVC BioPharma - Yalpi rentabellik|Cumberland Corp - Yalpi marja|QNTM - Yalpi marja|FibroGen, Inc. (FGEN) - Yalpi rentabellik|TELO: Yalpi foyda koeffitsiyenti|RANI (Rani Therapeutics Inc) - Yalpi marja|Yalpi foyda marjasi synergychc.com SNYR|Yalpi rentabellik Rallybio Corp. (RLYB)|LEXX - Yalpi foyda marjasi|Yalpi marja PULM (pulmatrix.com)|Yalpi foyda koeffitsiyenti PTHL (Pheton)|APM - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Lyra Therapeutics Inc LYRA|impactbiomedinc.com (IBO) - Yalpi rentabellik|TNF Pharma (TNFA) - Yalpi marja|YCBD (cbdmd.com) - Yalpi marja|Yalpi foyda bo'yicha rentabellik PainReform (PRFX)|Yalpi rentabellik Altamira Therapeutics (CYTO)|Yalpi foyda bo'yicha sotuv rentabelligi Lipella Pharma|Optinose - Yalpi foyda bo'yicha rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi pieris.com (PIRS)|PROC - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik PTPI|QLI: Yalpi marja|Yalpi foyda marjasi ACELYRIN Inc. (SLRN)|TFFP (TFF Pharmaceuticals, Inc) - Yalpi marja